How does Mahua help lower blood sugar levels?

Mahua (Madhuca longifolia) contains bioactive compounds including quercetin, myricetin, and saponins that may help regulate blood glucose. These compounds demonstrate antioxidant properties that may protect pancreatic beta cells and improve insulin sensitivity. Saponins may also slow carbohydrate absorption in the digestive tract. However, current evidence is limited to preliminary research (Evidence Level C), and well-designed clinical trials are needed to confirm these mechanisms in humans.

Can Mahua interact with diabetes medications?

Yes, Mahua has potential interactions with antidiabetic medications. Due to its blood sugar-lowering effects, combining Mahua with diabetes drugs like metformin, sulfonylureas, or insulin may cause additive hypoglycemic effects, potentially leading to dangerously low blood glucose levels. Patients taking diabetes medications should consult their healthcare provider before using Mahua and should monitor blood glucose levels closely if use is approved.

What is the recommended dosage for Mahua?

Traditional adult dosages for Mahua are 5-10 grams of dried flowers or 2-4 grams of bark prepared as a decoction, typically taken once or twice daily. These recommendations are based on traditional use rather than standardized clinical trials (Evidence Level C). Dosage may vary depending on the specific condition being addressed. Always start with the lowest effective dose and consult a qualified healthcare practitioner for personalized guidance.

Is Mahua safe to use during pregnancy?

No, Mahua is contraindicated during pregnancy and should be avoided. Traditional knowledge and available evidence indicate it is unsafe for pregnant women. The plant contains bioactive compounds that may adversely affect pregnancy outcomes. Additionally, fermented Mahua products pose additional risks due to alcohol content. Women who are pregnant, planning pregnancy, or breastfeeding should not use Mahua in any form. Consult a healthcare provider for safer alternatives.

What are the traditional uses of Mahua flowers?

Mahua flowers have been used traditionally by Indian tribal communities for centuries. The flowers are consumed as food and are fermented to produce alcoholic beverages. Medicinally, they have been used to support management of diabetes, bronchitis, and tonsillitis. The bark is also used for skin conditions. These uses are primarily based on traditional knowledge (Evidence Level C) rather than rigorous clinical validation. The flowers are rich in beta-carotene and have nutritional as well as therapeutic applications.

Mahua (Madhuca longifolia)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Madhuca longifolia, commonly known as Mahua, is an evergreen tree native to South Asia used traditionally for food and medicine [PMID:39000329, PMID:40612792]. It is recognized for its anti-inflammatory, anti-diabetic, and antimicrobial properties [PMID:39009828].

Contexte

Madhuca longifolia (Sapotaceae) is an economically important tree growing throughout the subtropical region of the Indo-Pak subcontinent, India, Nepal, and Sri Lanka [PMID:27407181, PMID:39000329].

Usages traditionnels

Traditional uses include treating fever, inflammation, rheumatism, ulcers, epilepsy, diabetes, impotence, skin ailments, heart diseases, cough, and nerve disorders [PMID:33656414, PMID:39009828, PMID:40612792, PMID:42206180]. Twigs are used as chewing sticks to maintain healthy gums [PMID:38348007], and the bark is used as a paste for cuts and wounds or as a decoction for diabetes [PMID:37928037]. Flowers are used as a tonic, appetizer, galactagogue, and carminative agent [PMID:40612792].

Composés actifs

Active constituents include Ascorbic acid, Riboflavin, Pantothenic acid, (4R)-2beta,3beta,23-trihydroxy-oleana-5,12-dien-28-oic acid, Quercetin, Nicotinic acid, and Bassiaic acid [PMID:39009828]. The flowers contain flavonoids, anthocyanins, phenolic acids, carotenoids, tannins, and saponins [PMID:31882088, PMID:42241758]. The seed oil contains palmitic (19%), stearic (15%), oleic (42%), and linoleic (24%) fatty acids [PMID:2272556].

Mécanisme d'action

In diabetic models, a hydroethanolic fraction of leaves may reverse mitochondrial dysfunction and modulate selective GLUT expression [PMID:38270737]. Bark extracts have been shown to induce apoptosis and increase reactive oxygen species (ROS) generation in melanoma cells [PMID:39000329].

Preuves cliniques

Preuve DOral Bacteria (Streptococcus mutans)

Stem extract demonstrated antibacterial activity against S. mutans in vitro [PMID:38348007]

Preuve DGastric Toxicity (Diclofenac-induced)

Aqueous leaf extract showed ameliorative activity against diclofenac-administered toxicity in rat stomach and intestine [PMID:33656414]

Preuve DRenal Cancer (DEN-induced)

Biofabricated silver nanoparticles using aqueous leaf extract attenuated renal cancer in rats by regulating oxidative stress and pro-inflammatory cytokines [PMID:32914714]

Preuve DMelanoma

Ethanol extract from the bark exhibited potent cytotoxic activity and sensitized human melanoma cells to dacarbazine in vitro [PMID:39000329]

Preuve DColon Carcinoma

Aqueous ethanolic bark extract exhibited potent cytotoxic effects in human colon cancer cells and showed synergy with SN-38 [PMID:42206180]

Preuve DDiabetes/Obesity

Sécurité et effets indésirables

Silver nanoparticles derived from M. longifolia aqueous leaf extract showed safety in renal histopathology in rat models [PMID:32914714].

Interactions médicamenteuses

Bark extract may potentiate the activity of the chemotherapeutic drug dacarbazine [PMID:39000329].

Synthèse des preuves

The current evidence is primarily based on in vitro studies and animal models (Level D), with some review articles (Level C) discussing traditional uses and nutritional properties. There are no human clinical trials (Level B) or meta-analyses (Level A) provided.

Sources PubMed

1.PMID: 27407181 (2016) — Functional characteristics, nutritional value and industrial applications of Madhuca longifolia seeds: an overview. · Journal of food science and technology
2.PMID: 38348007 (2024) — Evaluation of Antibacterial Activity of Madhuca longifolia (Mahua) Stem Extract Against Streptococcus mutans: An In Vitro Study. · Cureus
3.PMID: 41028891 (2025) — Sustainable carbon quantum dots from Mahua (Madhuca longifolia) for biomedical and environmental applications. · Scientific reports
4.PMID: 39009828 (2024) — Network Pharmacology Reveals Key Targets and Pathways of Madhuca longifolia for Potential Alzheimer's Disease Treatment. · Cell biochemistry and biophysics
5.PMID: 33656414 (2021)

Mahua

Sources et citations

Scoparia Dulcis

Enterolobium cyclocarpum

Bridelia Ferruginea

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Interactions médicamenteuses

Synthèse des preuves

Sources PubMed

Sources gouvernementales

Mahua

Sources et citations

Plantes associées

Scoparia Dulcis

Enterolobium cyclocarpum

Bridelia Ferruginea

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Interactions médicamenteuses

Synthèse des preuves

Sources PubMed

Sources gouvernementales